RARA CRAFT DATABASE for FDA Medical Devices

FDA Device Decisions, December 2025: Transcatheter Mitral Valve Replacement, Home Neurostimulation for Depression and Ten Original PMAs

日本語版

December 2025 brought ten original PMAs, up from two in November. Two of them are home-use head stimulators for depression: the Flow FL-100 (P230024), a transcranial direct current stimulation (tDCS) headset, and Proliv Rx (P250010), which stimulates the occipital and trigeminal nerves.

The same month FDA approved SAPIEN M3 (P250019), a transcatheter mitral valve replacement system for mitral regurgitation in patients unsuitable for surgery or transcatheter repair.

Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 289 510(k)s in December 2025, granted 2 De Novo requests and approved 10 original PMAs. These counts have not been reconciled with FDA's own figures. The site holds 510(k), De Novo and PMA records from 2015 onward, and counts for past months can change as the data are updated.

Counts by pathway

December 2025 next to the previous month and the same month a year earlier, with records assigned to a month by FDA decision date.

PathwayDecember 2025November 2025December 2024
510(k)289203289
De Novo222
PMA (original)1023
PMA supplement20878238

Records held in RA Craft Database, decisions through August 31, 2026.

510(k) clearances were 86 more than in November and equal to December 2024 (289). The 10 original PMAs compare with 2 in November and 3 a year earlier.

The busiest product codes

December's 510(k)s spread across 182 product codes. QIH (automated radiological image processing software) led with 10, followed by OHS (light based over the counter wrinkle reduction) with 8, IYN (system, imaging, pulsed doppler, ultrasonic) with 6, and CAW (generator, oxygen, portable), GEX (powered laser surgical instrument) and HRS (plate, fixation, bone) with 5 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions. If your code is on the list, enter it in the Product Code field on Search to see the records sorted by decision date.

De Novo: two classifications

December's two De Novo grants, both Class II, with the classification names and regulation numbers from each Classification Order:

  • QIKCAP System (DEN250004, HAI Solutions): Ultraviolet light-based microbial reduction device for luer-activated valves (21 CFR 880.6512)
  • LIAISON® XL MUREX Anti-HDV (DEN250032, DiaSorin, Inc.): Device to detect antibodies to hepatitis D Virus (21 CFR 866.3176)

"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.

QIKCAP applies ultraviolet-C (UVC) light to the septum of a needle-free connector for 10 seconds after the usual scrub-the-hub step, to help reduce microbial contamination. The LIAISON XL MUREX Anti-HDV assay detects antibodies to hepatitis D virus in people who are positive for hepatitis B surface antigen (HBsAg) and at risk of HDV infection.

Original PMAs: ten approvals

  • Atellica IM Total PSA II (P240021, Siemens Healthcare Diagnostics, Inc.): total prostate-specific antigen (PSA) measurement, used with digital rectal exam as an aid in detecting prostate cancer (product code MTF)
  • Flow FL-100 (P230024, Flow Neuroscience AB): a home-use tDCS headset for major depressive disorder (JXK)
  • ProVee System for BPH (P250011, Proverum, Ltd.): a nitinol implant placed in the prostatic urethra for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) (MER)
  • DIAM™ Spinal Stabilization System (P240043, Companion Spine France SAS): a silicone interspinous spacer for low back pain from single-level lumbar degenerative disc disease (NQO)
  • Zenflow Spring® Implant and Delivery System (P250007, Zenflow, Inc.): a removable prostatic urethral implant for BPH (MER)
  • ETHIZIA™ (P240035, Ethicon, Inc.): an absorbable hemostatic patch used as an adjunct in open liver surgery when standard techniques fail or are impractical (SGV)
  • GORE® VIABAHN® FORTEGRA Venous Stent (P250017, W. L. Gore & Associates, Inc.): a venous stent for symptomatic inferior vena cava obstruction (QTL)
  • Volt™ PFA System (P250022, Abbott Medical): a pulsed field ablation catheter for paroxysmal or persistent atrial fibrillation (QZI)
  • SAPIEN M3 Transcatheter Mitral Valve Replacement System (P250019, Edwards Lifesciences, LLC): transcatheter mitral valve replacement (NPU)
  • Proliv™Rx System (P250010, Neurolief, Ltd.): a headset that stimulates the occipital and trigeminal nerves, as adjunctive treatment for major depressive disorder that has not improved enough on an antidepressant (JXK)

Two prostatic urethral implants (ProVee and Zenflow) and two depression stimulators (Flow and Proliv) were approved in the same month. December also brought 208 PMA supplements, which cover changes to already approved PMA devices among other things.

Three devices worth a closer read

1. SAPIEN M3 Transcatheter Mitral Valve Replacement System (P250019, PMA). For symptomatic moderate-to-severe or severe mitral regurgitation in patients a heart team judges unsuitable for surgery or transcatheter edge-to-edge repair. A balloon-expandable bovine pericardial valve is placed inside a dock delivered through the femoral vein. According to the Summary of Safety and Effectiveness Data (SSED) that FDA published with the approval, in the single-arm ENCIRCLE study the one-year rate of death or heart failure rehospitalization was 25.2%, below the 45% performance goal. The device received Breakthrough Device designation in 2024.

2. Flow FL-100 (P230024, PMA). An app-controlled tDCS headset for home use in adults 18 and older with moderate to severe major depressive disorder, alone or with other treatment. According to the SSED, the pivotal study was a fully remote, double-blind, sham-controlled randomized trial in which participants took part from home; improvement on the 17-item Hamilton Depression Rating Scale (HDRS-17) was 2.3 points greater than with sham. The device received Breakthrough Device designation in 2022.

3. ProVee System for BPH (P250011, PMA). For BPH patients with a prostatic urethral length of at least 3.75 cm and a prostate volume of 30 to 80 cc, a nitinol implant is placed through the urethra to hold it open. According to the SSED, the double-blind, sham-controlled randomized ProVIDE trial enrolled 221 patients. Zenflow Spring, approved the same month, also rests on a sham-controlled randomized trial.

Compare the three devices

Open P250019, P230024 and P250011, star (☆) each one, tick "Compare" on all three in My Workspace and press "3 selected for comparison". The comparison table puts their Indications for Use side by side. Before relying on any of this, open "FDA Record" and "Summary PDF" on each record and read the source.

Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles